The groundbreaking therapy of the medication represents a exciting development in the care of the condition. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide942476.blogolize.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-81216440